Abstract:The aim of this research work is the synthesis of sulfamoyl-benzamides as a selective inhibitor for h -NTPDases. Sulfonamides are synthesized in aqueous medium from chlorosulfonylbenzoic acid while carboxamides are synthesized using carbodiimide coupling decorated with different biologically relevant substituents such as n -butyl, cyclopropyl, benzylamine, morpholine, and substituted anilines. In addition, sulfonamide-carboxamide derivatives were synthesized having the same substituents on either side. These compounds were screened against h -NTPDase activity, a main family of ectonucleotidases. Among the eight discovered isoforms of the h -NTPDases, four isoforms, h -NTPDase1, -2, -3, and -8, are involved in various physiological and pathological functions, for instance thrombosis, diabetes, inflammation, and cancer. The compound N -(4-bromophenyl)-4-chloro-3-(morpholine-4-carbonyl)benzenesulfonamide ( 3i ) was found to be the most potent inhibitor of h -NTPDase1 with an IC 50 value of 2.88 ± 0.13 μM. Similarly, the compounds N -(4-methoxyphenyl)-3-(morpholinosulfonyl)benzamide ( 3f ), 5-( N -benzylsulfamoyl)-2-chloro- N -(4-methoxyphenyl)benzamide ( 3j ) and 2-chloro- N -cyclopropyl-5-( N -cyclopropylsulfamoyl)benzamide ( 4d ) reduced the activity of the h -NTPDases2 with IC 50 in sub-micromolar concentrations. Against the h -NTPDase3, 3i was the potent compound with an IC 50 concentration of 0.72 ± 0.11 μM. The h -NTPDase8 was selectively blocked by the most potent inhibitor 2-chloro-5-( N -cyclopropylsulfamoyl)benzoic acid ( 2d ) with (IC 50 = 0.28 ± 0.07 μM). Moreover, the molecular docking studies of the potent inhibitors showed significant interactions with the amino acids of the respective h -NTPDase homology model proteins.

Benzothiophene-2-carboxamide derivatives as SENPs inhibitors with selectivity within SENPs family

Identification of SENP1 Inhibitors Through in Silico Screening and Rational Drug Design.

Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors.

2-(4-Chlorophenyl)-2-oxoethyl 4-Benzamidobenzoate Derivatives, a Novel Class of SENP1 Inhibitors: Virtual Screening, Synthesis and Biological Evaluation.

Activity Profiling of Human Desumoylating Enzymes (senps) with Synthetic Substrates Suggests an Unexpected Specificity of Two Newly Characterized Members of the Family

Research progress of SENP inhibitors and SENP inhibitor bioassay methods

A Potent and Selective Inhibitor for the UBLCP1 Proteasome Phosphatase.

Recent Research and Development of Inhibitors Targeting Sentrin-Specific Protease 1 for the Treatment of Cancers.

Design, Synthesis, and Biological Evaluation of Novel Phenol Ether Derivatives As Non-Covalent Proteasome Inhibitors.

Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors

Design, Synthesis and Biological Evaluation of Novel Non-peptide Boronic Acid Derivatives As Proteasome Inhibitors

Development and Evaluation of a Highly Reliable Assay for SUMO-Specific Protease Inhibito R S

Discovery of Benzothiazole Derivatives As Novel Non-Sulfamide NEDD8 Activating Enzyme Inhibitors by Target-Based Virtual Screening.

Identification of 2-substituted ethenesulfonic acid ester derivatives as novel, potent and selective inhibitors of protein tyrosine phosphatase 1B.

Identification of Novel 2-(Benzo[d]isoxazol-3-yl)-2-oxo-n-phenylacetohydrazonoyl Cyanide Analoguesas Potent EPAC Antagonists.

The allosteric effect of the upper half of SENP1 contributes to its substrate selectivity for SUMO1 over SUMO2

Structure-activity relationships of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as novel antagonists of exchange proteins directly activated by cAMP (EPACs)

Synthesis and biological evaluation of sulfamoyl benzamide derivatives as selective inhibitors for h-NTPDases

Discovery of seven-membered ring berberine analogues as highly potent and specific hCES2A inhibitors

A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics

Design, Synthesis, Evaluation and 3D-QSAR Analysis of Benzosulfonamide Benzenesulfonates As Potent and Selective Inhibitors of MMP-2